Sylvan

KKR has deepened its investment in Sylvan, a global leader in fungal biotechnology, by leading a new funding round. This significant capital injection, with participation from new and existing investors like Novo Holdings, will fuel Sylvan’s global expansion. The funds are earmarked for scaling production, enhancing R&D, and entering new growth markets, particularly in Asia, solidifying Sylvan’s position as a key player in sustainable fungal solutions across food, health, agriculture, and materials.